Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?

Authors

Rohit S. Loomba, Advocate Aurora HealthFollow
Saul Flores
Ronald BronickiFollow

Recommended Citation

Loomba RS, Flores S, Bronicki R. Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?. J Perinatol. 2021;41(4):905-906. doi:10.1038/s41372-021-00937-7

Affiliations

Advocate Children's Hospital

Document Type

Article

PubMed ID

33603108